D33.0 C71.0 C72.0 D33.1 D33.2 D33.3 D33.4 D33.7 D33.9
Conditions
Interventions
Group 1: Cliinical patient data are recorded. These will be linked with biological and molecular data of the tumors from the LOGGIC Bioclinical Databank
Sponsors
Charité - Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
No minimum to 21 Years
Inclusion criteria
Inclusion criteria: Diagnosis of LGG by neuropathology or neuroradiology as approved by the pertinent reference Centers, Age from birth to 21 years, signed informed consent by patients and parents
Exclusion criteria
Exclusion criteria: Diagnosis of a different brain tumor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The registry study does not have a conventional endpoint. The aim of the study is the registration of the natural disease course of low-grade glioma in childhood and adolescence | — |
Secondary
| Measure | Time frame |
|---|---|
| Epilepsy free survival, molecular and biological data, Tumor predisposition, Quality of survival | — |
Countries
Germany
Contacts
Public ContactPablo Hernáiz Driever
Charité - Universitätsmedizin Berlin
Outcome results
None listed